Clinicopathologic Analysis of CD10+ and CD10– Diffuse Large B-Cell Lymphoma
Open Access
- 1 August 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (2) , 183-190
- https://doi.org/10.1309/j7rn-uxay-55gx-bunk
Abstract
We analyzed 53 cases of diffuse large B-cell lymphoma (DLBCL) to determine whether expression of CD10 is a relevant biologic parameter. Tumor morpholKeywords
This publication has 32 references indexed in Scilit:
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- BCL2 Overexpression in Diffuse Large B-Cell LymphomaLeukemia & Lymphoma, 1999
- Diffuse large B‐cell lymphoma: is morphologic subdivision useful in clinical management?European Journal of Haematology, 1998
- BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.Proceedings of the National Academy of Sciences, 1991
- Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)Nature, 1991
- Small noncleaved cell lymphoma: An immunophenotypic study of 18 cases and comparison with large cell lymphomaHuman Pathology, 1986
- Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.Proceedings of the National Academy of Sciences, 1985
- Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study GroupHematological Oncology, 1984
- Anatomical distribution of CALL antigen expressing cells in normal lymphatic tissue and in lymphomasLeukemia Research, 1982
- A monoclonal antibody to human acute lymphoblastic leukaemia antigenNature, 1980